Genetics of Insulin Resistance
Insulin resistance is a condition where cells fail to respond normally to insulin, leading to elevated blood glucose, compensatory hyperinsulinaemia, and metabolic dysfunction. Genetic variants in insulin signalling, glucose transport, and pancreatic beta-cell function contribute to insulin resistance risk.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Insulin Resistance?
Insulin resistance underlies type 2 diabetes, metabolic syndrome, polycystic ovary syndrome, and non-alcoholic fatty liver disease. In the context of Long COVID, new-onset diabetes and insulin resistance have been reported following SARS-CoV-2 infection, which can damage pancreatic beta cells directly. Genetic variants in the insulin signalling cascade (IRS1, PIK3R1), glucose transporters (SLC2A4/GLUT4), adipokine pathways (ADIPOQ, LEPR), and transcription factors (TCF7L2, PPARG) collectively influence insulin sensitivity and diabetes risk.
Biological pathways commonly discussed in relation to Insulin Resistance
Research into Insulin Resistance and Glucose Metabolism has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Insulin Signalling
Insulin receptor (INSR) signals through IRS1/2, PI3K, and AKT to stimulate glucose uptake and suppress hepatic glucose production. Variants impairing this cascade reduce insulin sensitivity.
Glucose Transport
GLUT4 (SLC2A4) mediates insulin-stimulated glucose uptake in muscle and adipose tissue. Variants affecting GLUT4 expression or translocation reduce glucose disposal.
Beta Cell Function
Pancreatic beta cells secrete insulin in response to glucose. TCF7L2 variants — the strongest T2D risk variants — reduce GLP-1-stimulated insulin secretion. KCNJ11 and ABCC8 variants affect beta-cell potassium channel function.
Adipokine Signalling
Adipokines including adiponectin (ADIPOQ) and leptin (LEP/LEPR) regulate insulin sensitivity. ADIPOQ variants affecting adiponectin levels have modest insulin sensitivity effects.
Key genes studied in relation to Insulin Resistance
The following genes have been studied in relation to Insulin Resistance and Glucose Metabolism. These genes span the biological pathways most commonly discussed in this area of research.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Insulin Resistance. Each variant represents a position in the genome where individuals may carry different alleles.
12 variants total across genes studied in relation to Insulin Resistance.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Insulin Resistance.
This is not a diagnostic service. Genetic variants do not determine whether you have Insulin Resistance, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Insulin Resistance shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
Can COVID-19 cause insulin resistance or diabetes?
SARS-CoV-2 expresses ACE2 in pancreatic beta cells, and COVID-19 has been associated with new-onset diabetes and insulin resistance. The mechanisms may include direct beta-cell damage, stress hyperglycaemia, and immune-mediated pancreatic inflammation. Genetic predisposition to impaired beta-cell recovery may modify these outcomes.
What is TCF7L2 and why is it the strongest T2D risk gene?
TCF7L2 is a transcription factor in the WNT signalling pathway that regulates GLP-1 receptor expression in beta cells. The rs7903146 variant is the strongest single SNP associated with type 2 diabetes risk in European populations, reducing GLP-1-stimulated insulin secretion.
Which insulin resistance genes are studied?
Key genes include TCF7L2, PPARG, KCNJ11, ABCC8, IRS1, SLC2A4, ADIPOQ, LEPR, FTO, and MC4R. These cover insulin signalling, glucose transport, beta-cell function, and metabolic regulation.
Can consumer DNA data reveal insulin resistance risk?
Consumer DNA datasets include insulin resistance-associated variants including TCF7L2 rs7903146 and PPARG rs1801282. ChronicDNA analyses these for educational context — diabetes risk assessment requires clinical evaluation including blood glucose testing.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Insulin Resistance and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
7 genes · 12 variants analysed in relation to Insulin Resistance